Researchers at Israel’s Ben Gurion University and the US NIH have identified a trigger for the autoimmune disease Lupus. They have also developed what the media is calling a “miracle” molecule, that blocks the trigger in Lupus and other diseases, … Continue reading →

Researchers from Israel’s Ben-Gurion University and the University of California have discovered that a small molecule called IPW is able to heal a damaged Blood Brain Barrier (BBB). It can also alleviate the inflammation that leads to Alzheimer’s and other … Continue reading →

Israel’s Metabomed is developing treatments using small molecules that target and inhibit metabolic enzymes vital for cancer cells’ survival.  It currently has four pipeline programs. Metabomed has just raised a further $12.5 million of funds to help it prepare for … Continue reading →

Israeli intelligent scan analysis startup Zebra Medical (see here) is partnering with Johnson & Johnson subsidiary DePuy Synthes to jointly develop artificial intelligence technologies for spine and other orthopedic surgeries. https://www.calcalistech.com/ctech/articles/0,7340,L-3776155,00.html

Rabbi Elad Gadot recently donated one of his kidneys to a total stranger for whom he was a rare match. Years ago, Rabbi Gadot donated a liver lobe to his son Eliyahu (now in the IDF) who needed a liver … Continue reading →

As reported previously (see here), Israel’s MedAware prevents prescription errors and saves lives.  Now a 5-year Harvard study shows it would have cut $800 million a year from US Health costs. 70% of the errors detected would not have been … Continue reading →

As reported (here) previously, the synthetic injectable molecule from Israeli startup Raziel Therapeutics melts fat cells. RZL-12 converts white adipose tissue (WAT) into brown adipose tissue (BAT) after a single injection into subcutaneous fat. Raziel has just raised another $22 … Continue reading →

Israel’s Oncohost is working with Israel’s Technion to develop cutting-edge technology to characterize, analyze and predict patient response and resistance to cancer therapy. This enables personalized treatment strategies with improved outcomes & reduced side effects. http://oncohost.com/ https://www.jpost.com/Jpost-Tech/Hillels-Tech-Corner-Cancer-treatment-personalized-610032

The NOL pain monitoring technology from Israel’s Medasense (see here) helps clinicians treat non-communicating patients. The Israel Innovation Authority has just given Medasense a grant to test NOL at the Dorot Rehabilitation and Geriatric Medical Center in Netanya. https://finance.yahoo.com/news/medasense-pain-index-solution-treatment-121400637.html